Trial Profile
Efficacy and safety of ledipasvir and sofosbuvir in patients with chronic hepatitis C
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2019
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 07 Aug 2015 New trial record